OR WAIT null SECS
Wellthy Therapeutics announced the appointment of Theo Ahadome as Chief Business Officer.
“We have all seen how well-established technologies in one region can be applied in other geographies, leapfrog and accelerate the advancement of global innovation. Wellthy is in a firm position to lead the evolution of the global digital care industry - from point solutions to true patient companions that solve challenges in all stages of the disease and treatment journey. I am excited about the health equity mission of Wellthy, its robust operating system, and proven success delivering outcomes in various therapeutic areas,” added Theo Ahadome.
Before joining Wellthy Therapeutics, Theo was Senior Vice President of Commercial at Happify Health (now Twill), where he led the company’s specialty solutions partnerships. He also previously held commercial positions at Science 37 and Amgen. Theo holds a Masters in Business Administration (MBA) from Duke University, Fuqua School of Business and an MPhil in Technology Policy from the University of Cambridge.